Anxiety Medication Overview of Risperidone

Risperidone, an atypical antipsychotic sold under the brand name Risperdal, is a medication typically used to treat schizophrenia, manic symptoms in people with bipolar disorder, and irritability in the autistic. However, it is sometimes prescribed off-label to treat anxiety disorders, typically those that have failed to respond to more conventional medications like antidepressants.

A study presented in 2004 found that low doses of risperidone (from.5 mg to 1.5 mg) showed promise as an additional medication for patients with a treatment-resistant generalized anxiety disorder (GAD). According to lead researcher Dr. Olga Brawman-Mintzer, MD, "We found that patients who had low doses of risperidone did have significantly greater improvement in the primary measure, using the Hamilton Anxiety Rating Scale (HAM-A). It was statistically significant in comparison to placebo without significant side-effect.”

Risperidone is also sometimes used in combination with a selective serotonin reuptake inhibitor (SSRI) to manage treatment-resistant obsessive-compulsive disorder (OCD). While it appears useful in this combination, it has not been shown to be effective at treating OCD when used alone.

Risperidone and other atypical antipsychotics have some significant side effects that limit their use in the treatment of anxiety disorders, but they may be helpful in some cases and have fewer troublesome side effects when taken in lower doses.

Photo: Pixabay

More Articles

Specific phobias are the most common type of anxiety disorder that is defined as an irrational fear of or aversion to a situation or specific...

Everyone who lives with bothersome anxiety symptoms should have a pouch or pocket in their bag or backpack that is an emergency calm-kit.

...

While anxiety disorders in children are often overlooked, they are actually the most common childhood psychiatric problem. Children can suffer...

We all know that bullying and other stressful social situations can have lasting effects on a person, but a new study from New York’s Rockefeller...

You heard a rumor of more layoffs at work, have not met your monthly quota, and are finishing up an important presentation at the last minute. You...

SITEMAP